Advertisement

Tiaobu Xinshen Recipe (调补心肾方) Improved Mild Cognitive Impairment of Alzheimer’s Disease Patients with Xin (Heart) and Shen (Kidney) Deficiency

  • Zhi-ying LinEmail author
  • Tian-wen Huang
  • Jun-shang Huang
  • Guan-yi Zheng
Clinical Experience

Abstract

Objective

To observe the intervention effects of Tiaobu Xinshen Recipe (调补心肾方, TXR) on patients with mild cognitive impairment caused by Alzheimer’s disease (MCI-AD).

Methods

Totally 88 MCI-AD patients with syndrome of Xin (Heart) and Shen (Kidney) deficiency were assigned to the experimental group (47 cases, treated with TXR) and the control group (41 cases, treated with donepezil hydrochloride) using a random number table. Final recruited qualified patients were 44 cases in the experimental group and 39 cases in the control group. The therapeutic course was 12 weeks. Neuropsychological scales [mini mental state examination (MMSE) and Montreal cognitive assessment (MoCA)], and Chinese medicine (CM) dementia syndromes scales were performed in all patients, and results were compared between groups or intra-group before and after treatment.

Results

MMSE and MoCA scores of the two groups were increased after treatment compared with those before treatment (P<0.05). But there was no statistical difference in MMSE or MOCA scores after treatment between the two groups (P>0.05). CM dementia syndrome score was significantly decreased after treatment in the experimental group compared with the control group (P<0.01). Visual spatial and executive function scores and delayed recall scores of the two groups were increased compared with those before treatment (P<0.01).

Conclusion

TXR could effectively improve cognitive impairment of MCI-AD patients with syndrome of Xin and Shen deficiency.

Keywords

Tiaobu Xinshen Recipe mild cognitive impairment Alzheimer’s disease mini mental state examination Montreal cognitive assessment Chinese medicine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Notes

Acknowledgment

We are grateful to all the participants and staffs in the trial.

Author Contributions

Lin ZY designed the research and analyzed the data. Lin ZY and Huang TW drafted the manuscript. Huang JS managed and coordinated the study. Zheng GY assisted with subject recruitment and supervised training sessions. All authors have read and approved the final version of the manuscript.

Conflict of Interest

All the authors declare that they have no competing interests.

References

  1. 1.
    Petersen RC. Mild cognitive impairment. Continuum (Minneap Minn) 2016;22 (2 Dementia):404–418.Google Scholar
  2. 2.
    Greenberg SM, Tennis MK, Brown LB, Gomez-Isla T, Hayden DL, Schoenfeld DA, et al. Donepezil therapy in clinical practice: a randomized crossover study. Arch Neurol 2000;57:94–99.CrossRefGoogle Scholar
  3. 3.
    Lin ZY, Huang TW, Huang JS, Zheng GY, Fu KL, Chen XY, et al. Nourishing Xin and Shen method improved mild cognitive impairment due to subcortical small vessel disease: a clinical study. Chin J Integr Tradit West Med (Chin) 2015;35:41–45.Google Scholar
  4. 4.
    Do LLTN. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders (DSM-JV). Encyclopedia of child behavior and development. Springer US, 2011:84-85.Google Scholar
  5. 5.
    Zheng XY, ed. Guidelines for clinical research of new drugs of traditional Chinese medicine. Beijing: China Medical Science and Technology Press; 2002:91–99.Google Scholar
  6. 6.
    Pfeffer RI, Kurosaki TT, Harrah CH Jr, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol 1982;37:323–329.CrossRefGoogle Scholar
  7. 7.
    Radloff LS. The CED-D scale: a self-report depression scale for research in the general population. Applied Psycholog Measurement 1977;1:385–401.CrossRefGoogle Scholar
  8. 8.
    Zheng GC, ed. Brain aging and senile dementia. Shanghai: Shanghai Science and Technology Press; 1995:229–231.Google Scholar
  9. 9.
    Nasreddine ZS, Phillip NA, Bedirian V. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695–699.CrossRefGoogle Scholar
  10. 10.
    Petersen RC, Parisi JE, Dickson DW, Johnson KA, Knopman DS, Boeve BF, et al. Neuropathologic features of amnestic mild cognitive impairment. Arch Neurol 2006;63:665–672.CrossRefGoogle Scholar
  11. 11.
    Espinosa A, Alegret M, Valero S, Hernández I, Mauleón A, Rosende-Roca M, et al. A longitudinal follow-up of 550 mild cognitive impairment cases: evidence for large conversion to dementia rates and detection of major risk factors involved. J Alzheimers Dis 2013;34:769–780.CrossRefGoogle Scholar
  12. 12.
    Zhou AH, Jia JP, Min BQ, Yang PJ. Comparison of neuropsychological features of mild cognitive impairment in different etiology. Chin J Neurol (Chin) 2008;41:242–246.Google Scholar
  13. 13.
    Reed B, Mungas DM, Kramer JH, Ellis W, Vinters HV, Zarow C, et al. Profiles of neuropsychological impairment in autopsy-defined Alzheimer’s disease and cerebrovascular disease. Brain 2007;130:731–739.CrossRefGoogle Scholar
  14. 14.
    Hugo J, Ganguli M. Dementia and cognitive impairment: epidemiology, diagnosis, and treatment. Clin Geriatr Med 2014;30:421–442.CrossRefGoogle Scholar
  15. 15.
    Lin SM, Wang J, Zhou RQ, Yu ZH. Clinical study of Alzheimer’s disease from Xin and Shen. Chin J Integr Tradit West Med (Chin) 2003;23:583–586.Google Scholar
  16. 16.
    Yang Y, Liu JP, Fang JY, Wang HC, Wei Y, Cao Y, et al. Effect and safety of Huannao Yicong Formula on patients with mild-to-moderate Alzheimer’s disease: a randomized, double-blinded, donepezil-controlled trial. Chin J Integr Med 2019;25:574–581.CrossRefGoogle Scholar
  17. 17.
    Chen JX, Li ZW. Lu Xi’s experience in the treatment of senile dementia. Guangming J Chin Med (Chin) 2010;25:1140.Google Scholar
  18. 18.
    Liu Y, Liu W, Li J, Tang S, Wang M, Huang W, et al. A polysaccharide extracted from Astragalus membranaceus residue improves cognitive dysfunction by altering gut microbiota in diabetic mice. Carbohydr Polym 2019;205:500–512.CrossRefGoogle Scholar
  19. 19.
    Li M, Li H, Fang F, Deng X, Ma S. Astragaloside J attenuates cognitive impairments induced by transient cerebral ischemia and reperfusion in mice via anti-inflammatory mechanisms. Neurosci Lett 2017;639:114–119.CrossRefGoogle Scholar
  20. 20.
    Deng M, Sun H, Shen J, Fan Y, Zhang L, Zhang J. Radix Angelica Sinensis promotes synaptic plasticity during cognitive recovery in chronically stressed rats. Curr Neurovasc Res 2015;12:232–239.CrossRefGoogle Scholar
  21. 21.
    Xin J, Zhang J, Yang Y, Deng M, Xie X. Radix Angelica Sinensis that contains the component Z-ligustilide promotes adult neurogenesis to mediate recovery from cognitive impairment. Curr Neurovasc Res 2013;10:304–315.CrossRefGoogle Scholar
  22. 22.
    Yang B, Liu B, Liu Y, Han H, Kuang H. Cognitive enhancement of volatile oil from the stems of Schisandra chinensis Baill in Alzheimer’s disease rats. Can J Physiol Pharmacol 2018;96:550–555.CrossRefGoogle Scholar
  23. 23.
    Wang M, Bi W, Fan K, Li T, Yan T, Xiao F, et al. Ameliorating effect of Alpinia oxyphylla-Schisandra chinensis herb pair on cognitive impairment in a mouse model of Alzheimer’s disease. Biomed Pharmacother 2018;97:128–135.CrossRefGoogle Scholar
  24. 24.
    Zhao X, Liu C, Xu M, Li X, Bi K, Jia Y. Total lignans of Schisandra chinensis ameliorates A β 1–42-induced neurodegeneration with cognitive impairment in mice and primary mouse neuronal cells. PLoS One 2016;11:e0152772.CrossRefGoogle Scholar

Copyright information

© The Chinese Journal of Integrated Traditional and Western Medicine Press and Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Zhi-ying Lin
    • 1
    Email author
  • Tian-wen Huang
    • 2
  • Jun-shang Huang
    • 3
  • Guan-yi Zheng
    • 1
  1. 1.Department of Traditional Chinese MedicineThe Affiliated Union Hospital of Fujian Medical UniversityFuzhouChina
  2. 2.Department of NeurologyThe Affiliated Union Hospital of Fujian Medical UniversityFuzhouChina
  3. 3.Key Laboratory of Traditional Chinese Medicine for the Treatment of Brain DysfunctionFujian Academy of Traditional Chinese MedicineFuzhouChina

Personalised recommendations